TPTakeda Pharmaceutical

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

Create this for my brand
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1 email from Takeda Pharmaceutical screenshot

Captured Announcement

Takeda press release announcing the simultaneous launch of ORZEYFUL for Narcolepsy Type 1 patients in Japan and China.

Clean corporate header featuring brand logo and slogan, followed by a split hero banner with a laboratory visual. The body includes bold headline text, publication date, text CTA, and an embedded feedback poll above a gray footer.

Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.